Dynamic Renoscintigraphy in the Evaluation of Renal Function in Patients with Chronic Heart Failure

Apply

Dynamic Renoscintigraphy in the Evaluation of Renal Function in Patients with Chronic Heart Failure

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 19, Issue 1

Abstract

he relationship of cardiac and renal pathology has long attracted the attention of both cardiologists and nephrologists. In the past decade was noted that acute or chronic kidney damage is associated with high cardiovascular mortality [1]. On the other hand, in cardiovascular pathology an early assessment of renal damage is necessary for stratify the risk, develop strategies and management of such patients [2]. The aim of study is radionuclide estimation of the incidence and severity of renal dysfunction in patients with chronic heart failure (CHF).The study included 235 patients (220 men and 15 women, mean age 56.24 ± 7.35 years) with a primary diagnosis: coronary heart disease complicated by CHF NYHA I-III; 169 (72%) pts suffered one or more acute myocardial infarctions with the formation of postinfarction cardiosclerosis. All patients underwent dynamic radionuclide Renoscintigraphy with 99mТс- diethylenetriaminepentaacetic acid (99mТс-DTPA). The following parameters were calculated: total glomerular filtration rate (GFR, mL/min) and GFRs for each kidney; blood clearance (min) as half-time of radiopharmaceutical excretion from blood; halftime of radiotracer drainage from renal collecting system (Т1/2 (min), separately for the left and right kidneys); half-time of radiotracer drainage from renal parenchyma (Т1/2PAR, separately for the left and right kidneys). The scintigraphy studies were performed with gamma camera Philips Forte (Philips Medical Systems, Netherlands). Processing of the acquired scintigrams was performed using JetStream® Workspace Release 3.0 software package (Philips Medical Systems, Netherlands)According to the results of radionuclide Renoscintigraphy functional renal activity disorders were not identified in only 44 (18.7%) out of 235 patients studied. However, only 57 (24.3%) patients had chronic renal pathology in anamnesis, including: chronic pyelonephritis - in 32 patients, urolithiasis - in 15 patients, polycystic kidney disease - in 6 patients, chronic renal insufficiency - in 2 patients and 1 case of renal artery stenosis and nephropathy. Decreased glomerular filtration rate of one or both kidneys, in greater and lesser extent, was found in 177 (75.3%) out of the 235 patients studied. This is also demonstrated in the studies of McAlister FA [3] which showed the presence of functional renal insufficiency in 56.6% of patients with CHF NYHA II-III. The mean GFR values were 105.13 ± 8.36 mL/min (total GFR); 47.60 ± 6.57 mL/min for the left kidney and 57.52 ± 6.01 mL/min for the right kidney. In 49 (20.9%) patients, we found pronounced renal dysfunction (the GFR decline in one or both kidneys by more than 30% of normal values). The majority of patients (101 (43%) patients) had moderately pronounced changes in the filtration function and manifested GFR decline by 15-30% of normal values. Minor disorders ( < 15 % of normal values) were identified in 27 out of 235 (11.5%) patients studied. It is known that at early stages of heart insufficiency a decrease in renal blood flow does not affect GFR or affects it slightly, then as the disease progresses there is a decrease in GFR due to the renal perfusion reduction and increase in renal vascular resistance [4]. But according to other authors, renal functional reserve may be reduced at the early stages of CHF (NYHA I) and even in cases of clinically asymptomatic left ventricular dysfunction [5]. Evacuation disorders in parenchyma were found in 93 patients (39.6% out of the examined patients). The identified disorders were mostly moderate and minor (not more than 15 minutes over the normal range upper limit) (57 (24.3%) and 18 (7.7%) patients, respectively). The exceptions were 18 patients who had a significantly delayed indicator clearance (T1/2PAR was more than 35 min). The latter fact should be emphasized because it indicates that the indicator excretion disorder in these patients was due to changes in the renal parenchyma that was above the pelvicalyceal system level and indicated renal tubular reabsorption disorders. On the basis of this, the deviation of such indicators as Т1/2PAR from the normal range can also be regarded as the result of damage to the central and renal hemodynamics in patients with coronary heart disease complicated with chronic CI [6,7]. It should be noted that the last two indicators show the activity of excretion processes occurring in the nephron. The delay in indicator excretion from pelvicalyceal system occurred in 65 (27.7%) cases and mostly (45 patients) it was a small extent (no more than 6 minutes over the upper limit of normal range). The disorder of evacuation function was mild in 14 patients (6.0%) and quite significantly pelvicalyceal activity was reduced in 6 (2.6%) patients (Т1/2 was more than 30 minutes).

Authors and Affiliations

Zh V Vesnina

Keywords

EP ID EP622396
DOI 10.26717/BJSTR.2019.19.003250
Views 140
Downloads 0